Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP), a biopharmaceutical company with a market capitalization of $24.67 million, has entered into a material definitive agreement with YA II PN, LTD, ...
South San Francisco-based Lyell Immunopharma , Inc., currently valued at $178 million by market capitalization, has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback